172 related articles for article (PubMed ID: 6681484)
1. The lack of prognostic significance of biopsies after radiotherapy for prostatic cancer.
Cox JD; Kline RW
Semin Urol; 1983 Nov; 1(4):237-42. PubMed ID: 6681484
[No Abstract] [Full Text] [Related]
2. The prognostic significance of biopsies after radiotherapy for prostatic cancer.
Scardino PT
Semin Urol; 1983 Nov; 1(4):243-52. PubMed ID: 6399610
[No Abstract] [Full Text] [Related]
3. Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate.
Anscher MS; Clough R; Robertson CN; Prosnitz LR; Dahm P; Walther P; Donatucci CF; Albala DM; Febbo P; George DJ; Sun L; Moul JW
Prostate Cancer Prostatic Dis; 2006; 9(3):254-60. PubMed ID: 16880828
[TBL] [Abstract][Full Text] [Related]
4. The influence of percentage of preradiation needle biopsies with adenocarcinoma and total radiation dose on the pathologic response of unfavorable prostate adenocarcinoma.
Goldstein NS; Kestin LL; Vicini FA; Martinez AA
Am J Clin Pathol; 2002 Jun; 117(6):927-34. PubMed ID: 12047145
[TBL] [Abstract][Full Text] [Related]
5. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of post-irradiation prostate biopsies.
Kuban DA; el-Mahdi AM; Schellhammer PF
Oncology (Williston Park); 1993 Feb; 7(2):29-38; discussion 40, 43-4, 47. PubMed ID: 7679918
[TBL] [Abstract][Full Text] [Related]
7. Results of three dimensional conformal radiotherapy and hormonal therapy for local recurrence after radical prostatectomy.
Schwarz R; Krüll A; Tribius S; Alberti W
Strahlenther Onkol; 2005 Jul; 181(7):442-7. PubMed ID: 15995837
[TBL] [Abstract][Full Text] [Related]
8. [Radiotherapy of prostatic cancer].
Izumiyama K; Imajo Y; Hiratsuka J; Nishishita S; Furukawa Y; Suzuki M; Tanaka H
Gan No Rinsho; 1990 Aug; 36(9):999-1002. PubMed ID: 2381055
[TBL] [Abstract][Full Text] [Related]
9. The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study.
Nguyen TD; Poortmans PM; van der Hulst M; Studer G; Pigois E; Collen TD; Belkacemi Y; Beckendorf V; Miralbell R; Scandolaro L; Soete G; Villa S; Gez E; Thomas O; Krengli M; Jovenin N
Radiother Oncol; 2005 Dec; 77(3):286-9. PubMed ID: 16307812
[TBL] [Abstract][Full Text] [Related]
10. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
[TBL] [Abstract][Full Text] [Related]
11. Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma.
Nurani R; Wallner K; Merrick G; Virgin J; Orio P; True LD
J Urol; 2007 Nov; 178(5):1968-73; discussion 1973. PubMed ID: 17868717
[TBL] [Abstract][Full Text] [Related]
12. [Prostatic cancer. Reliability of clinical staging and the prognostic significance of age, clinical stage and tumor morphology].
Mihatsch MJ; Rist M; Ohnacker H; Oberholzer M; Spichtin HP; Schmassmann A; Perret A; Torhorst J; Rutishauser G
Z Urol Nephrol; 1983 May; 76(5):281-97. PubMed ID: 6880416
[No Abstract] [Full Text] [Related]
13. A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy.
Nichol A; Chung P; Lockwood G; Rosewall T; Divanbiegi L; Sweet J; Toi A; Bayley A; Bristow R; Crook J; Gospodarowicz M; McLean M; Milosevic M; Warde P; Catton C
Radiother Oncol; 2005 Jul; 76(1):11-7. PubMed ID: 15990187
[TBL] [Abstract][Full Text] [Related]
14. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
[TBL] [Abstract][Full Text] [Related]
15. Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery.
Choo R; Morton G; Danjoux C; Hong E; Szumacher E; DeBoer G
Radiother Oncol; 2005 Feb; 74(2):163-7. PubMed ID: 15734204
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
Maru N; Ohori M; Kattan MW; Scardino PT; Wheeler TM
Hum Pathol; 2001 Aug; 32(8):828-33. PubMed ID: 11521227
[TBL] [Abstract][Full Text] [Related]
17. Benign positive margins after radical prostatectomy means a poor prognosis--pro.
Djavan B; Milani S; Fong YK
Urology; 2005 Feb; 65(2):218-20. PubMed ID: 15708025
[No Abstract] [Full Text] [Related]
18. Patterns of local failure following prostate brachytherapy.
Stone NN; Stock RG; White I; Unger P
J Urol; 2007 May; 177(5):1759-63; duscussion 1763-4. PubMed ID: 17437808
[TBL] [Abstract][Full Text] [Related]
19. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP
J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380
[TBL] [Abstract][Full Text] [Related]
20. Needle biopsy of recurrent adenocarcinoma of the prostate after radical prostatectomy.
Ripple MG; Potter SR; Partin AW; Epstein JI
Mod Pathol; 2000 May; 13(5):521-7. PubMed ID: 10824923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
